About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Washington | 1,247 Studies

Clinical Trials Breast CancerWashington

Breast Cancer Clinical Trials in Washington

Find 1,247 clinical trials for breast cancer near Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 301-320 of 1,247 trials

CompletedA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerThis study is looking at whether Metformin, an agent that is commonly used to treat diabetes, can decrease or affect the ability of breast cancer cells to grow and whether…NCT01101438·Anchorage, Alaska and 343 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedCelecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal CancerRATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells.NCT00305643·Santa Rosa, California and 13 others

Active not recruitingUsing FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE StudyThis phase II trial studies how well FDG-PET/CT works in assessing the response of patients with breast cancer that has spread to the bones or mostly to the bones (bone-dominant…NCT04316117·Birmingham, Alabama and 103 others

CompletedDS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]This study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before.NCT03523585·Chandler, Arizona and 226 others

WithdrawnS0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307RATIONALE: Gathering information over time from imaging and laboratory tests of women receiving bisphosphonates for breast cancer may help doctors learn more about long-term bone…NCT00873808·Seattle, Washington

Active not recruitingA Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerThe reason for this study is to see if the study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or…NCT04188548·Gilbert, Arizona and 73 others

Active not recruitingMRI Characterization of Mammographically Detected DCISThis is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS).NCT03495011·Seattle, Washington

Active not recruitingImproving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.NCT05334732·Washington D.C., District of Columbia and 2 others

CompletedVaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving TrastuzumabThis phase I/II trial studies the side effects of vaccine therapy and to see how well it works in treating patients with stage IV major histocompatibility complex, class I, A2…NCT00194714·Seattle, Washington

CompletedGroup-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast CancerThis randomized clinical trial studies a group-based lifestyle intervention or usual care in measuring biomarker levels in participants at high risk for breast cancer.NCT01874184·Seattle, Washington

CompletedCyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineThis phase I trial studies the safety and the ability to expand laboratory-treated T cells when given together with cyclophosphamide or denileukin diftitox in treating patients…NCT00228358·Seattle, Washington

RecruitingA Study of Sigvotatug Vedotin in Advanced Solid TumorsThis trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have…NCT04389632·Anchorage, Alaska and 157 others

RecruitingPhase IIIb Study of Ribociclib + ET in Early Breast CancerThe purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant…NCT05827081·Birmingham, Alabama and 228 others

TerminatedTreating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart FailureBreast cancer patients undergoing trastuzumab-based HER2-directed therapy are at risk of heart function decline or heart failure symptoms, but it is unknown if, when, and for how…NCT03879629·Phoenix, Arizona and 4 others

CompletedAlemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantRATIONALE: Alemtuzumab and glucocorticoids, such as prednisone or methylprednisolone, may be an effective treatment for acute graft-versus-host disease caused by a donor stem cell…NCT00410657·Seattle, Washington

CompletedPanobinostat and Letrozole in Treating Patients With Metastatic Breast CancerRATIONALE: Panobinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Estrogen can cause the growth of breast cancer cells.NCT01105312·Scottsdale, Arizona and 171 others

CompletedPhase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer PatientsThis will be a multi-center, prospective, randomized, single-blinded, placebo-controlled phase II trial of trastuzumab + nelipepimut-S/GM-CSF versus trastuzumab + GM-CSF alone.NCT02297698·Santa Monica, California and 23 others

Active not recruitingRobotic vs. Open NSM for Early Stage Breast CancerThis study evaluates the safety and effectiveness of the da Vinci SP Surgical System compared to Open NSM in Nipple Sparing Mastectomy procedures.NCT05720039·Irvine, California and 14 others

RecruitingStudy of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus…NCT06072612·Phoenix, Arizona and 78 others

RecruitingTesting the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerThis phase II trial studies how well nab-paclitaxel, durvalumab, and tremelimumab with or without personalized synthetic long peptide vaccine (neoantigen vaccine) works in…NCT03606967·Orange, California and 29 others

PreviousPage 16 of 63Next

Other Conditions in Washington

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma